| Thanks to SoCalBio Weekly Update Sponsor |
Coming in 2010 Benefiting Time: 10:00am - 8:30pm Where: Old Ranch Country Club, Seal Beach, California |
Take Advantage of SoCalBio's Group Purchasing Program to Cut the Cost of Doing Business |
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
| March 1st, 2010  | |
Thanks to Participants in the Feb 25 Networking Forum Focusing on the Biosciences in the Media
|
Frontiers of Medicine
| The Wireless Future of Medicine
Eric
Topol, director of the Scripps Translational Science Institute, spoke at TEDMED last October about wireless technology changing the face of medicine. TEDMED just released the video of the talk ... See video |
Emerging Companies
| Librede, Inc. -- a Biotech Startup -- Joins UCLA Tech Incubator to Develop Technologies for Drug Discovery, Screening
 Founded by Jacob Schmidt (photo right) of the Department of Bioengineering at the UCLA School of Engineering, Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.... Read more |
 | |
| RSVP Now for Upcoming SoCalBio Events | 
SoCalBio Networking Forum in Orange County
Showcasing Non-Invasive Medical Technologies More InfoDate: March 25, 2010
Time: 7:00 am - 9:30 pm
Location: UCI University Club
RSVP: https://www.123signup.com/register?id=jyrvf ************************************************
SoCalBio Executive Roundtable Discussion
Regenerative Medicine Luncheon and Discussion
(Open only to executives and managers in regenerative medicine companies)
Date: April 6, 2010
Time 11 - 2:00
Location: TBA
By Invitation Only (for more info, contact SoCalBio at scbc@socalbio.org or call 213-236-4890)
*************************************************
SoCalBio HR Symposium
Best Practices in Designing Wellness Programs
Join us to learn how to craft wellness programs to improve employee health, reduce medical claims, and guarantee a return on investment (Open only to HR professionals in medical device, IVD, biotech and generic pharma firms)
Date: April 15, 2010
Time: 9:00am - 1:30pm
Location: One Lambda Corp. (Canoga Park)
By Invitation Only (for more info, contact SoCalBio at scbc@socalbio.org or call 213-236-4890)
Join the SoCalBio HR Network on LinkedIn
*************************************************
SoCalBio Regulatory Best Practice Workshop
The Shifting Paradigm in FDA Process Validation
This SoCalBio workshop focuses on the FDA's guidelines regarding Process Validation. It is designed for device and pharma regulatory affairs professionals to learn what is required to approach process validation from a life cycle perspective and incorporates modern risk management and quality systems tools and concepts. |
New SoCalBio Members
| 
An independent provider of clinical equipment maintenance and management solutions .. Learn more |
Market Trends
| Betting On Botox: The Maker of Botox and Two More Pharmaceutical Stocks Look Ripe for Bullish Exploits Author contends that, while Allergan has dropped more than 6% since the beginning of the year, the stock is currently perched on support at its rising 32-week moving average. The equity has not finished a week below this key trend line since late March 2009, and could now use it to springboard higher ... Read moreICU Medical: High Growth Potential and an Attractive ValuationAnalyst contends that, with a strong balance sheet, attractive valuation, potential to continue expanding market share as well as strategically acquiring products to enhance top line growth, The San
Clemente-based ICU Medical is a great buy for any portfolio ... Read more |
|  |
| Clinical Studies | Dermatology Study Identifies Genetic Key In Treatment Of Female Hair Loss
The Irvine-based HairDX announced the results of a six month pilot study that presents, for the first time, evidence that genetic mechanisms may predict treatment response to Finasteride for postmenopausal female Androgenetic Alopecia (female hair loss)... Read more |
| Collaborations | Valeant Enters Cosmetics Collaboration with Spear PharmaceuticalsThe Aliso Viejo-based company said it has entered into an agreement with Spear Pharmaceuticals, Inc. for rights to commercialize
Refissa, a prescription-based topical tretinoin cream used to diminish fine wrinkles and fade irregular pigmentation due to sun damage. ... Read more |
| Personnel | HemaCare Names van der Wal President and CEO The Van Nuys-based hemapheresis company announced today that Pete van der Wal has replaced Mr. John Doumitt as President & CEO. Mr. Van der
Wal, who also joins the Company's Board of Directors, was previously HemaCare's Vice President, Sales & Marketing. His previous positions included senior Sales, Marketing, Operations and Business Development roles at Syncor International, as well as President and CEO of Comprehensive Imaging Solutions ... Read more MannKind Elects Ex-Novartis Executive, James Shannon, to its Board of Directors Dr. Shannon is a recognized pharmaceutical industry leader with more than 20 years of experience in senior leadership positions, including serving as Head of Global Development at Novartis Pharma AG in Basel, Switzerland ... Read more
VertiFlex Announces Appointment of William
Duffell, Ph.D., Vice President, Global Clinical ResearchThe San
Clemente-based spinal device company said Dr. Duffell brings over 25 years' experience as a senior Clinical, Regulatory and Market Development executive, possessing a wealth of successful accomplishments in both start-up and large companies. Most recently, her served as Sr. Vice President, Global Government Affairs and Global Regulatory and Quality Assurance with Gambro, a Swedish private equity owned firm which develops and markets medical devices, biologics and pharmaceuticals for hemodialysis, peritoneal dialysis and cell therapy.... Read more |
| Jobs Available | 
C3 Jian (Inglewood) Founded in 2005, C3 Jian, Inc ("C3") is a clinical-stage biotechnology company based in Los Angeles, California whose technologies were pioneered in the laboratories of Dr. Wenyuan Shi at UCLA. We are developing novel products to diagnose, treat and prevent human, animal and plant diseases. Lead compounds are focused on bacterial and fungal infections, especially those occurring on mucosal surfaces and in industrial biofilms. Company is seeking: Baxter (Los Angeles & Westlake Village)Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Company is seeking: Grifols Biologicals (Los Angeles)At its Los Angeles facility, Grifols manufactures plasma derived biopharmaceutical products. Company is seeking: St Jude Medical (Sylmar)
St Jude Cardiac Management Division in Sylmar designs and manufactures pacemakers. Company is seeking: |
| About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
